Secretion of proinflammatory cytokines by normal human melanocytes in response to lipopolysaccharide

Acta Biochimica Polonica

Volumn 58, Issue 4, 2011, Pages 507-511

  Tam, Irena ^a   Stepień, Krystyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Lipopolysaccharide; Melanocytes; Proinflammatory cytokines

Indexed keywords

EID: 84860484367     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2011_2217     Document Type: Article

References (45)

1. Abdel-Malek Z, Kadekaro A (2006) Human pigmentation: its regulation by ultraviolet light and by endocrine, paracrine, and autocrine factors. In The Pigmentary System: Physiology and Pathophysiology - 2nd edn. Nordlund J, Boissy R, Hearing V, King R, Oetting W, Ortonne J, eds, pp 410-420. Blackwell Publishing Ltd, Oxford, UK.
2. Ahn J, Park T, Jin S, Kang H (2008a) Human melanocytes express functional Toll-like receptor 4. Exp Dermatol 17: 412-417.
3. Ahn J, Jin S, Kang H (2008b) LPS induces melanogenesis through p38 MAPK activation in human melanocytes. Arch Dermatol Res 300: 325-329.
4. Brajac I, Kaštelan M, Prpič-Massari L, Periša D, Lončarek K, Malnar D (2009) Melanocyte as a possible key cell in the pathogenesis of psoriasis vulgaris. Med Hypotheses 73: 254-256.
5. Brzoska T, Luger T, Maaser C, Abels C, Bohm M (2008) α-Melanocytestimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29: 581-602.
6. Burbach G, Ansel J, Amstrong Ch (2001) Cytokines in the skin. In The Biology of the Skin. Freinkel R, Woodley D, eds, pp 299-332. The Parthenon Publishing, New York, USA.
7. Clark J (2001) Role of cytokines in pathology of melanoma and use of biologic response modifiers in melanoma. In Methods in Molecular Medicine, Melanoma Techniques and Protocols: Molecular Diagnosis, Treatment, and Monitoring. Nickoloff B, Hood L, eds, pp 241-267. Humana Press, New Jersey, USA.
8. Dayer J (2002) Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin Exp Rheumatol 20: S14-S20.
9. Elias E, Hasskamp J, Sharma B (2010) Cytokines and growth factors expressed by human cutaneous melanoma. Cancers 2: 794-808.
10. Hari A, Flach T, Shi Y, Mydlarski R (2010) Toll-like receptors: role in dermatological disease. Mediators Inflamm 2010: 1-16.
11. Hasegawa J, Goto Y, Murata H, Takata M, Saida T, Imokawa G (2008) Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin. Pigment Cell Melanoma Res 21: 687-699.
12. Herrling T, Jung K, Fuchs J (2008) The role of melanin as protector against free radicals in skin and its role as free radical indicator in hair. Spectrochim Acta Part A 69: 1429-1435.
13. Imokawa G (2006) Paracrine interactions of melanocytes in pigmentary disorders. In The Pigmentary System: Physiology and Pathophysiology - 2nd edn. Nordlund J, Boissy R, Hearing V, King R, Oetting W, Ortonne J, eds, pp 421-444. Blackwell Publishing Ltd, Oxford, UK.
14. Jin H, Kang H (2010) Activation of toll-like receptors 1, 2, 4, 5, and 7 on human melanocytes modulate pigmentation. Ann Dermatol 22: 486-489.
15. Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E (2010) Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocytes differentiation antigens. Int J Cancer 127: 1625-1636.
16. Kozłowska K, Zarzeczna M, Cichorek M (2001) Characterization of NO and cytokine release by transplantable melanoma cell lines in relationship to their differentiation. Arch Immunol Ther Exp 49: S103-S109.
17. Lázár-Molnár E, Hegyesi H, Tóth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12: 547-554.
18. Lu Y, Zhu W, Tan C, Yu G, Gu J (2002) Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Pigment Cell Res 15: 454-460.
19. Mackintosh J (2001) The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol 211: 101-113.
20. Mattei S, Colombo M, Melani C, Silvani A, Parmiani G, Herlyn M (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853-857.
21. Mohagheghpour N, Waleh N, Garger S, Dousman L, Grill L, Tusé D (2000) Synthetic melanin suppresses production of proinflammatory cytokines. Cell Immunol 199: 25-36.
22. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15: 87-92.
23. Pandya A, Guevara I (2000) Disorders of hyperpigmentation. Dermatol Clin 18: 91-98.
24. Plonka P, Passeron T, Brenner M, Tobin D, Shibahara S, Thomas A, Slominski A, Kadekaro A, Hershkovitz D, Peters E, Nordlund J, Abdel-Malek Z, Takeda K, Paus R, Ortonne J, Hearing V, Schallreuter K (2009) What are melanocytes really doing all day long...?. Exp Dermatol 18: 799-819.
25. Radtke S, Wüller S, Yang X, Lippok B, Mütze B, Mais C, Schmitz-Van de Leur H, Bode J, Gaestel M, Heinrich P, Behrmann I, Schaper F, Hermanns H (2010) Cross-regulation of cytokine signalling proinflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J Cell Sci 123: 947-959.
26. Romero-Graillet C, Aberdam E, Clement M, Ortonne J, Ballotti R (1997) Nitric oxide produced by ultraviolet irradiated keratinocytes stimulates melanogenesis. J Clin Invest 99: 635-642.
27. Sasaki M, Horikoshi T, Uchiwa H, Miyachi Y (2000) Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res 13: 248-252.
28. Shang J, Eberle J, Geilen C, Hossini A, Fecker L, Orfanos C, Tebbe B (2002) The role of nuclear factor-kappaB and melanogenesis in tumor necrosis factor-alpha-induced apoptosis of normal human melanocytes. Skin Pharmacol Appl Skin Physiol 15: 321-329.
29. Slominski A (2009) Neuroendocrine activity of the melanocytes. Exp Dermatol 18: 760-763.
30. Slominski A, Goodman-Snitkoff G (1992) Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res 12: 753-756.
31. Slominski A, Paus R, Mihm M (1998) Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 18: 3709-3716.
32. Slominski A, Gomez-Sanchez C, Foecking M, Wortsman J (1999) Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cell. FEBS Lett 445: 364-366.
33. Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80: 979-1020.
34. Slominski A, Tobin D, Shibahara S, Wortsman J (2004a) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84: 1155-1228.
35. Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, Sweatman T, Marcos J, Dunbar C, Tuckey R (2004b) A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271: 4178-4188.
36. Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, Wortsman J (2005) CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 288: E701-E706.
37. Slominski A, Zbytek B, Slominski R (2009) Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer 124: 1470-1477.
38. Smit N, Le Poole I, Wijngaard R van den, Tigges A, Westerhof W, Das P (1993) Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res 285: 356-365.
39. Ste{ogonek}pień K (2010) The role of melanocytes in protection against photooxidative stress. Post Bioch 56: 290-297.
40. Swope V, Abdel-Malek Z, Kassem L, Nordlund J (1991) Interleukins 1 α and 6 and tumor necrosis factor -α are paracrine inhibitors of human melanocytes proliferation and melanogenesis. J Invest Dermatol 96: 180-185.
41. Swope V, Sauder D, McKenzie R, Sramkoski R, Krug K, Babcock G, Nordlund J, Abdel-Malek Z (1994) Synthesis of interleukin-1α and β by normal human melanocytes. J Invest Dermatol 102: 749-753.
42. Tam I, Ste{ogonek}pień K (2007) Melanocytes - immunocompetent pigmented cells. Post Dermatol Alergol 24: 188-193.
43. Van Der Meer J, Helle M, Aerden L (2005) Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection. Eur J Immunol 19: 413-416.
44. Verstrepen L, Bekaert T, Chau T, Tavernier J, Chariot A, Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell Mol Life Sci 65: 2964-2978.
45. Yu N, Zhang S, Zuo F, Kang K, Guan M, Xiang L (2009) Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9. J Dermatol Sci 56: 113-120.